BridgeBio Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-732.94	-543.35	-653.25	-484.65	-586.45
Depreciation & Amortization	5.43	6.08	6.49	6.77	5.84
Stock-Based Compensation	133.02	95.8	108.71	91.56	99.51
Other Adjustments	199.63	-111.3	5.27	-61.25	-12.43
Change in Receivables	-134.72	-2.97	15.33	15.17	-19.75
Changes in Inventories	-25.31	-	-	-	-
Changes in Accounts Payable	26.61	1.51	2.78	-0.35	2.83
Changes in Accrued Expenses	108	29.9	1.46	-14.4	32.72
Changes in Unearned Revenue	-11.43	21.88	-5.44	15.26	-
Changes in Other Operating Activities	-14.21	-18.28	-9.08	12.4	-20.2
Operating Cash Flow	-445.91	-520.73	-527.72	-419.49	-497.93
Capital Expenditures	-1.1	-0.93	-1.31	-4.82	-13.25
Purchases of Intangible Assets	-8.5	-7.98	-	-1.5	-35
Purchases of Investments	-28.2	-114.08	-137.26	-193.06	-643.28
Proceeds from Sale of Investments	13.3	183.91	193.11	532.52	477.04
Other Investing Activities	-	-0.14	-0.5	120	13.65
Investing Cash Flow	-24.49	60.78	54.03	453.15	-200.83
Long-Term Debt Issued	575	950	-	-	1,204
Long-Term Debt Repaid	-474.46	-473.42	-	-20.49	-124.12
Net Long-Term Debt Issued (Repaid)	100.54	476.58	-	-20.49	1,080
Issuance of Common Stock	34.15	322.9	459.22	8.08	20.46
Repurchase of Common Stock	-62.5	-7.53	-6.88	-1.56	-204.75
Net Common Stock Issued (Repurchased)	-28.35	315.37	452.34	6.52	-184.28
Other Financing Activities	287.11	-43.5	-0.8	0.84	-158.95
Financing Cash Flow	359.29	748.46	451.54	-13.13	736.45
Net Cash Flow	-111.1	288.51	-22.15	20.52	37.69
Free Cash Flow	-447.01	-521.66	-529.03	-424.32	-511.18
FCF Margin	-89.03%	-235.09%	-5686.62%	-546.46%	-733.23%
Free Cash Flow Per Share	-2.33	-2.80	-3.25	-2.88	-3.54
Levered Free Cash Flow	-536.4	-19.02	-648.29	-486.81	525.09
Unlevered Free Cash Flow	-435.73	-554.08	-612.45	-497.34	-568.68

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.